Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

The news was reported by Bloomberg late Wednesday, citing people familiar with the matter. In the final days of President Joe Biden's term, Moderna (MRNA) won the $590 million contract to use its mRNA ...

There is no escaping from the fact that the British company has proved perennially disappointing for investors. Around £10bn ...

13, 2024 — Influenza or flu virus remains infectious in refrigerated ... learned after the first season following the approval of RSV vaccines. The vaccine effectively prevented severe illness ...

Britain's health regulator said on Friday it has approved Moderna's vaccine to protect patients aged 60 and over against ...

What should you know about RSV and who can get it? In many cases, there is a difference for adults and children, ...

Advancements in prevention strategies against respiratory syncytial virus (RSV) are transforming pediatric care. Experts recommend the use of prophylactic monoclonal antibodies for immunizing infants.

A cohort study found that nearly three fourths of infants received respiratory syncytial virus protection with either nirsevimab or through exposure to maternal RSVpreF in the 2023-2024 season.

Respiratory syncytial virus is a common, highly contagious illness that often causes mild upper respiratory symptoms, akin to a cold. In babies, particularly those with tiny airways, RSV can cause the ...

A young woman’s repeated loss of consciousness is traced to severe anaemia caused by warm autoimmune haemolytic anaemia, a rare complication of respiratory syncytial virus.